MedTrace Logo

Effects of a Microalgae Extract Dietary Supplement on Gut Health, Anxiety, and Immune Function

NCT06425094 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2026-02-17

No results posted yet for this study

Summary

This study will be conducted to determine the effect of daily Tetrasol consumption in supporting gut health using assessments of gastrointestinal symptoms (GSRS) and bowel habits (BSS) as primary outcome measures. The investigators also intend to explore fecal and blood biomarkers of intestinal permeability/function, determination of anxiety and stress levels through both validated assessments and saliva and blood biomarkers, establishment of intervention safety and tolerability through comprehensive metabolic panels and overall compliance, explore the effects of the intervention on inflammation and acute stress (Cold Presser Test), blood lipid profiles, and gut microbiota composition as secondary outcomes.

Conditions

  • Stress
  • Gastrointestinal Problem
  • Anxiety
  • Gastrointestinal Symptoms

Interventions

DIETARY_SUPPLEMENT

Microalgae Extract Capsules

Tetrasol extract

DIETARY_SUPPLEMENT

Placebo

maltodextrin \& vegetable magnesium stearate

Sponsors & Collaborators

  • Mycrophyt LLC

    collaborator UNKNOWN

  • Colorado State University

    lead OTHER

Principal Investigators

  • Tiffany L Weir, MSc,PhD · Colorado State University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-05
Primary Completion
2024-05-24
Completion
2025-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06425094 on ClinicalTrials.gov